Alprazolam manufacturing factory busted in Valsad, drugs worth ₹22 crores seized; four held

New Delhi:  In a major blow to the synthetic drugs manufacturing, the Directorate of Revenue Intelligence (DRI) has busted a clandestine factory located in a sparsely populated area off the Gujarat State Highway (SH) 701, in Valsad, Gujarat, The factory engaged in production of Alprazolam, a psychotropic substance under the NDPS Act, 1985.

The operation codenamed “Operation White Cauldron” resulted in the seizure of Alprazolam worth ₹22 crore and the arrest of four persons, including the masterminds, who are financiers and manufacturers, as well as the intended recipient of the drug.

Acting on specific intelligence, DRI officers mounted discreet surveillance on the identified manufacturing facility. On 4th November 2025, a swift and coordinated raid was conducted, which led to uncovering a full-scale illegal manufacturing unit. The search resulted in the seizure of the following:

  • 9.55 kg of Alprazolam (finished form)
  • 104.15 kg of Alprazolam (semi-finished form)
  • 431 kg of raw materials, including key chemicals such as p-Nitrochlorobenzene, Phosphorous Pentasulfide, Ethyl Acetate, and Hydrochloric Acid
  • Full industrial-scale processing setup, including reactors, centrifuge, industrial refrigeration unit, and heating mantle.

The operation led to the arrest of two key persons, directly involved in the manufacturing and financing of Alprazolam, and an employee assisting them in production. The recipient of the drug, who had come from Telangana to collect it, was also apprehended, bringing the total arrests to four.

Preliminary investigation revealed that the manufactured Alprazolam was intended for supply to Telangana, potentially for mixing in Toddy. Notably, the DRI had busted a similar Alprazolam manufacturing unit in August 2025 in Atchuthapuram, Anakapalli District, Andhra Pradesh. The seized 119.4 kg of Alprazolam was also destined for Telangana for mixing with Toddy.

This year itself, the DRI has dismantled four clandestine drugs manufacturing facilities through intelligence-driven operations, underscoring its continuous vigilance, operational excellence, and unwavering commitment to the Government’s Nasha Mukt Bharat Abhiyaan by protecting citizens from the menace of narcotic and psychotropic substances.

Related Posts

Pharma companies in a flux over Trump’s 200% tariff move on generics

India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

CDSCO declares 159 drug samples as NSQs in June

CDSCO declares 159 drug samples as NSQs in June